Medical & Pharmaceutical Waste
Companies collecting and treating medical and pharmaceutical waste.
Market snapshot
These figures describe Hazardous Waste Management (7.2.3), the segment that Medical & Pharmaceutical Waste sits within — not Medical & Pharmaceutical Waste on its own.
Hazardous waste (NAICS 562112/562211) is sized under Industrial Services (Industrial Waste Management) to avoid double-counting; it is cross-referenced here as the environmental-sector home but not re-sized.
Business model & economics
Revenue model
Hazardous-waste collection, treatment, and disposal fees
Key economics
- Recurring revenue
- High
- EBITDA margin
- Strong
- Capex intensity
- High
recurring regulated-waste service
permitted-infrastructure economics
Characteristics
- Consolidated around hazardous-waste majors.
- Permitted facilities create high entry barriers.
- PFAS and emerging contaminants a growth driver.
Geographic concentration
Hazardous waste management concentrates in heavy-industry and petrochemical states — Ohio and Texas.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 562112/562211. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Hazardous-waste majors
- Environmental-services strategics
- PE-backed waste platforms
What’s driving deals
- Regulation- and compliance-driven demand.
- PFAS and emerging-contaminant treatment.
- Permitted-infrastructure consolidation.
Find Medical & Pharmaceutical Waste acquisition targets
Search Acquisera’s index for companies classified under Medical & Pharmaceutical Waste (7.2.3.3) and build a targeted deal pipeline.
Search companies